Bonnefont, X
DrAfter123/DigitalVision Vectors GLP-1 drugs show promise in managing chronic migraines Chronic migraine patients taking GLP-1s are associated with fewer ER visits, hospitalizations and treatment interventions than those taking a common first-line migraine drug, a study shows
Reactive Oxygen Species (ROS) Attenuation Studies indicate that MT-1mediated cAMP elevation enhances antioxidant defense mechanisms in melanocytes, reducing UV-induced ROS accumulation and oxidative DNA damage through upregulation of superoxide dismutase and catalase activity (Abdel-Malek et al., Endocrine Reviews, 2010)
Pencek R, Blickensderfer A, Li Y, Brunell SC, Anderson PW (2012) Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index